76 related articles for article (PubMed ID: 3086327)
1. Interleukin 3 and cell cycle progression.
Kelvin DJ; Chance S; Shreeve M; Axelrad AA; Connolly JA; McLeod D
J Cell Physiol; 1986 Jun; 127(3):403-9. PubMed ID: 3086327
[TBL] [Abstract][Full Text] [Related]
2. Lipoxygenase metabolism is required for interleukin-3 dependent proliferation and cell cycle progression of the human M-07e cell line.
Miller AM; Allen BS; Ziboh V
J Cell Physiol; 1997 Mar; 170(3):309-15. PubMed ID: 9066788
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.
Razin E; Ihle JN; Seldin D; Mencia-Huerta JM; Katz HR; LeBlanc PA; Hein A; Caulfield JP; Austen KF; Stevens RL
J Immunol; 1984 Mar; 132(3):1479-86. PubMed ID: 6198393
[TBL] [Abstract][Full Text] [Related]
4. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts.
Peters SO; Kittler EL; Ramshaw HS; Quesenberry PJ
Exp Hematol; 1995 May; 23(5):461-9. PubMed ID: 7536685
[TBL] [Abstract][Full Text] [Related]
5. IL-1 inhibits B cell differentiation in long term bone marrow cultures.
Dorshkind K
J Immunol; 1988 Jul; 141(2):531-8. PubMed ID: 3260256
[TBL] [Abstract][Full Text] [Related]
6. Mode of action of erythropoietin (Epo) in an Epo-dependent murine cell line. II. Cell cycle dependency of Epo action.
Tsuda H; Sawada T; Kawakita M; Takatsuki K
Exp Hematol; 1989 Mar; 17(3):218-22. PubMed ID: 2917620
[TBL] [Abstract][Full Text] [Related]
7. MC3T3-G2/PA6 preadipocytes support in vitro proliferation of hemopoietic stem cells through a mechanism different from that of interleukin 3.
Kodama H; Hagiwara H; Sudo H; Amagai Y; Yokota T; Arai N; Kitamura Y
J Cell Physiol; 1986 Oct; 129(1):20-6. PubMed ID: 3489721
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells.
Rottem M; Hull G; Metcalfe DD
Exp Hematol; 1994 Nov; 22(12):1147-55. PubMed ID: 7523167
[TBL] [Abstract][Full Text] [Related]
9. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
Davis L; Lipsky PE
J Immunol; 1986 May; 136(10):3588-96. PubMed ID: 3486215
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of purified murine hemopoietic stem cells in serum-free cultures stimulated with purified stem-cell-activating factor.
Migliaccio AR; Visser JW
Exp Hematol; 1986 Dec; 14(11):1043-8. PubMed ID: 3536544
[TBL] [Abstract][Full Text] [Related]
11. A preliminary report: preparations containing Interleukin-3 (IL-3) promote proliferation of multipotential stem cells (CFUs) in the mouse.
Garland JM; Crompton S
Exp Hematol; 1983 Sep; 11(8):757-61. PubMed ID: 6414839
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation of mouse T cell-dependent bone marrow-derived mast cells by rat serum does not change their unique phenotype.
Stevens RL; Bloes WF; Seldin DC; Razin E; Katz HR; Austen KF
J Immunol; 1984 Nov; 133(5):2674-80. PubMed ID: 6332858
[TBL] [Abstract][Full Text] [Related]
13. Restorative effect of IL-3 on adherence of cloned hemopoietic progenitor cell to stromal cell.
Minguell JJ; Hardy CL
Exp Hematol; 1993 Jan; 21(1):55-60. PubMed ID: 8417960
[TBL] [Abstract][Full Text] [Related]
14. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.
Ihle JN; Keller J; Oroszlan S; Henderson LE; Copeland TD; Fitch F; Prystowsky MB; Goldwasser E; Schrader JW; Palaszynski E; Dy M; Lebel B
J Immunol; 1983 Jul; 131(1):282-7. PubMed ID: 6190911
[TBL] [Abstract][Full Text] [Related]
15. Permissive role of interleukin 3 (IL-3) in proliferation and differentiation of multipotential hemopoietic progenitors in culture.
Suda T; Suda J; Ogawa M; Ihle JN
J Cell Physiol; 1985 Aug; 124(2):182-90. PubMed ID: 3930522
[TBL] [Abstract][Full Text] [Related]
16. B cell growth-promoting activity of recombinant human interleukin 4.
Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
[TBL] [Abstract][Full Text] [Related]
17. Resumption of cell cycle in BALB/c-3T3 fibroblasts arrested by polyamine depletion: relation with "competence" gene expression.
Charollais RH; Mester J
J Cell Physiol; 1988 Dec; 137(3):559-64. PubMed ID: 3142887
[TBL] [Abstract][Full Text] [Related]
18. The relative roles of interleukins 1, 2, and 3 in the regulation of T cell differentiation.
Ihle JN; Keller J
Kroc Found Ser; 1984; 18():399-421. PubMed ID: 6442348
[TBL] [Abstract][Full Text] [Related]
19. Unbalanced growth and cell death in HeLa S3 cultures treated with DNA synthesis inhibitors.
Frankfurt OS
J Cell Physiol; 1981 Apr; 107(1):115-22. PubMed ID: 7012161
[TBL] [Abstract][Full Text] [Related]
20. The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells.
Jelinek DF; Lipsky PE
J Immunol; 1985 Mar; 134(3):1690-701. PubMed ID: 3871457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
